TY - JOUR
T1 - Gouty arthropathy
T2 - Review of clinical manifestations and treatment, with emphasis on imaging
AU - Weaver, Jennifer S.
AU - Vina, Ernest R.
AU - Munk, Peter L.
AU - Klauser, Andrea S.
AU - Elifritz, Jamie M.
AU - Taljanovic, Mihra S.
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Gout, a crystalline arthropathy caused by the deposition of monosodium urate crystals in the articular and periarticular soft tissues, is a frequent cause of painful arthropathy. Imaging has an important role in the initial evaluation as well as the treatment and follow up of gouty arthropathy. The imaging findings of gouty arthropathy on radiography, ultrasonography, computed tomography, dual energy computed tomography, and magnetic resonance imaging are described to include findings of the early, acute and chronic phases of gout. These findings include early monosodium urate deposits, osseous erosions, and tophi, which may involve periarticular tissues, tendons, and bursae. Treatment of gout includes non-steroidal anti-inflammatories, colchicine, glucocorticoids, interleukin-1 inhibitors, xanthine oxidase inhibitors, uricosuric drugs, and recombinant uricase. Imaging is critical in monitoring response to therapy; clinical management can be modulated based on imaging findings. This review article describes the current standard of care in imaging and treatment of gouty arthropathy.
AB - Gout, a crystalline arthropathy caused by the deposition of monosodium urate crystals in the articular and periarticular soft tissues, is a frequent cause of painful arthropathy. Imaging has an important role in the initial evaluation as well as the treatment and follow up of gouty arthropathy. The imaging findings of gouty arthropathy on radiography, ultrasonography, computed tomography, dual energy computed tomography, and magnetic resonance imaging are described to include findings of the early, acute and chronic phases of gout. These findings include early monosodium urate deposits, osseous erosions, and tophi, which may involve periarticular tissues, tendons, and bursae. Treatment of gout includes non-steroidal anti-inflammatories, colchicine, glucocorticoids, interleukin-1 inhibitors, xanthine oxidase inhibitors, uricosuric drugs, and recombinant uricase. Imaging is critical in monitoring response to therapy; clinical management can be modulated based on imaging findings. This review article describes the current standard of care in imaging and treatment of gouty arthropathy.
KW - CT
KW - Crystalline arthropathy
KW - Dual energy CT
KW - Gout
KW - Imaging
KW - Magnetic resonance imaging
KW - Monosodium urate crystals
KW - Radiography
KW - Sonography
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85121777132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121777132&partnerID=8YFLogxK
U2 - 10.3390/jcm11010166
DO - 10.3390/jcm11010166
M3 - Review article
SN - 2077-0383
VL - 11
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 1
M1 - 166
ER -